close
close

Sagility India IPO Day 1: GMP, Subscription Status, Review, Other Details. Apply or not?

Sagility India IPO Day 1: GMP, Subscription Status, Review, Other Details. Apply or not?

Sagility India IPO: The initial public offering (IPO) of Sagility India Limited hit the primary market in India today. Bidding for Sagility India IPO will remain open till November 7, 2024. This means Sagility India IPO subscription will remain open from Tuesday to Thursday this week. The healthcare solutions provider company has fixed an IPO price band for Sagility India at 28 to 30 pieces. The company aims to raise 2,106.60 crore from this initial offer, which is entirely an offer for sale (OFS). Meanwhile, the company’s shares are available in the gray market ahead of the IPO subscription opening date at Sagility India. Conformable Exchange observers, Sagility India shares are trading at a premium of 3 on the gray market today.

Sagility India IPO Details

1) Sagility India IPO GMP: According to stock market watchers, the company’s shares are trading at a premium of 3 on the gray market today.

2) Sagility India IPO Price: The healthcare solutions provider company has a fixed price band of the public issue at 28 to 100.

3) Sagility India IPO Date: The auction for the public edition will remain open from November 5-7, 2024.

4) Sagility India IPO Size: The company aims to raise 2,106.60 crore from this initial offer which is entirely an OFS. This means that the net proceeds from the public issue will go into the pockets of the promoters who sell their stake in the company.

5) Sagility India IPO Lot Size: A bidder can apply in lots, and a lot in the book building problem compares 500 shares of the company.

6) Sagility India IPO Allotment Date: The most likely date for allotment of the shares is Friday, November 8, 2024.

7) Sagility India IPO Registrar: Link Intime India Private Limited has been appointed as the official registrar of the construction edition of the book.

8) Sagility India IPO Listing Date: The book building issue is proposed for listing on BSE and NSE. The most likely date for the stock listing is November 12, 2024.

9) Sagility India IPO Lead Managers: ICICI Securities, IIFL Securities, Jefferies India and JP Morgan India have been appointed as lead managers to the public issue.

Sagility India IPO: Apply or not?

10) Sagility India IPO Analysis: Labeling the book-building issue Prathamesh Masdekar, research analyst at StoxBox, said: “In January 2024, the company served 5 of the top 10 sign-up payers in the US. Financially, the company’s operating income has increased. by 9.6% to Rs 1,223 for the quarter ended June 30, 2024, from Rs 1,116 for the quarter ended June 30, 2023, and by 12.69% to Rs 4,753 in FY24, 218 crore The company has reported EBITDA margins of 23.5% and 17.8% respectively for the quarter ended June 30, 2024. The issue is valued at a P/E of 56.6x based on FY24 earnings, which is considered fair. We therefore recommend a ‘SUBSCRIBE’ rating for the issue.”

Master Capital also assigned a “buy” tag to the public issue, saying, “US healthcare operations spending grew at a CAGR of approximately 3.2% from 2014 to 2023 and was valued at approximately 201, USD 1 billion ( 16.8 trillion) in 2023. This spending is expected to grow at a CAGR of approximately 5.2% to reach approximately $258.9 billion ( 21.6 trillion) in 2028 as a result of increasing aging population, rising prevalence of chronic diseases, and various government initiatives aimed at improving healthcare services, among other factors. Complex services, stringent compliance requirements, complex performance measures, and multifaceted workflows characterize the US healthcare industry. These challenges require the involvement of specialized service providers with the experience to effectively navigate and manage these complexities. Sagility India Limited is one of the leading healthcare specialists with comprehensive coverage in the healthcare payer and provider markets. The company’s deep, long-term and expanding customer relationships between payers and healthcare providers contribute to customer loyalty and retention. Investors interested in the company can invest in the IPO for the long term.”

In addition to these, BP Equities, Marwadi Shares and Finance and Ventura Securities have assigned a ‘subscribe’ tag to the public issue.

Disclaimer: The opinions and recommendations presented in this article are those of the individual analysts. These do not represent the views of Mint. We advise investors to consult certified experts before making any investment decisions.